Pinnacle Medicines Raises $89 Million in Series B Financing
DOYLESTOWN, PA — Pinnacle Medicines recently closed an $89 million Series B financing round to advance its oral peptide drug programs and expand research and development capabilities, the company announced.
Pinnacle Medicines Raises $89 Million in Series B Financing Read More